On this page

What happened

NIH’s August 25, 2026 report discussed a July 23 Science paper on three-dimensional genome organization in Alzheimer’s disease. The prefrontal-cortex analysis used postmortem tissue from 20 donors aged 75 or older: ten with Alzheimer’s and ten controls. Researchers combined measurements of DNA organization and gene activity in individual cells. Alzheimer’s samples showed more contacts between distant DNA segments and fewer between nearby segments, alongside changes in the separation of normally dense, inactive and looser, active chromatin.

Why it matters

DNA’s arrangement inside a nucleus helps influence which genes can be used. Connecting changes in that arrangement with gene activity can reveal cellular patterns that measurements of gene sequence alone would miss. The findings offer hypotheses about molecular disruption in Alzheimer’s, but do not show that genome organization was the original cause of disease. This article focuses on the prefrontal study, titled “Single-cell multiomics connects 3D genome and transcriptome alterations in Alzheimer’s disease,” rather than combining it with a separate hippocampal ageing study discussed in the same NIH report.

Scope and limitations

Postmortem comparisons capture associations at the time represented by the donated tissue. The small donor cohort and the disease’s many interacting processes limit causal conclusions and generalization. Researchers did not change DNA organization in patients or test a supplement, treatment or cognitive outcome after an intervention. The result is therefore a molecular research finding, not a new diagnostic test or a demonstrated way to reverse dementia. The July primary paper and August NIH coverage are separately dated in the sources.

This sourced news summary and translation were prepared with AI assistance. Source links, the news date and research limitations are disclosed; this is not a claim of independent medical expert review. News production method.

Sources

Research news is not medical advice or a recommendation to use a substance. Read findings in the context of the study design, participants and limitations. Editorial standards.

← All news